Royal Bank of Canada and Leerink Partners lowered price targets and ratings for Boston Scientific.
1 report, 1 independent
Updated Aug 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Royal Bank of Canada and Leerink Partners lowered price targets and ratings for Boston Scientific.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Boston Scientific
worldwide developer, manufacturer and marketer of medical devices
-
Royal Bank of Canada
financial institution in Canada
Related events
- Financial firms including Royal Bank of Canada, Truist Financial, TD Cowen, and Barclays have announced price target increases for Medpace.
- Royal Bank of Canada provided a price target and reaffirmed a sector perform rating for Plains All American Pipeline.
- Royal Bank of Canada lowered its target price for Arthur J. Gallagher & Co. in a research report.
- CIBC, TD Cowen, Scotiabank, and Royal Bank of Canada set price targets and ratings for a stock.
- Royal Bank of Canada raised price objectives and Truist Financial boosted price targets for Ingram Micro on August 1, 2026.